Inhibitory effect 131I-antiAFP McAb-DOX-BSA nanoparticles on hepatocellular carcinoma bearing nude mice
Faquan JI,Ning QI,Dongsheng ZHANG,Jia ZHANG,Jie ZHANG,Anping JI,Ling BAI,Minghua DU,Longjiang ZHANG
DOI: https://doi.org/10.16016/j.1000-5404.201709228
2018-01-01
Abstract:Objective To determine the anti-tumor effect of 131 I-antiAFP monoclonal antibodydoxorubicin-bovine serum albumin nanoparticles (131 I-antiAFP McAb-DOX-BSA-NP) on hepatocarcinoma bearing nude mice.Methods The antiAFP McAb-DOX-BSA-NP were prepared and then labelled with radioiodine.Tumor xenograft model was established by transplanting human hepatoma BEL-7402 cells in nude mice.Then the model mice were randomly divided into 5 groups, that is, blank control group (group A,normal saline), 131I treatment group (group B), 131I-antiAFP McAb treatment group (group C), 131 I-antiAFP McAb-DOX-BSA-NP treatment group (group D), and antiAFP McAb-DOX-BSA-NP treatment group (group E), with 6 mice in each group.The agents were injected around the tumor mass, with per animal receiving DOX 40 μg and 131I 0.2 mCi in a total volume of 0.2 mL.The tumor volume was measured in 4, 9, 14 and 20 d.The nude mice in groups B, C and D treated with radionuclide were examined with SPECT in 24, 48,96 and 196 h for radioactive counting.Results The labeled product presented as clear solution, with a pH value of 7.4, radioactive chemical purity of ＞ 99％, and activity of 3.91 mCi/mL.The radioactive chemical purity became 97.17％, 97.10％ and 95.22％ in 1, 2 and 4 h respectively, when in the 0.2 mol/L PB buffer, which indicating good stability of the prepared nanoparticles.The tumor size was significantly smaller in the groups B, C, D and E than the group A (P ＜ 0.05).The tumor growth rate was most strongly suppressed in the group D, with obvious differences when compared with those in groups B, C and E (P ＜0.05).SPECT indicated that there was no statistical difference in the radioactive count in groups B, C and D in 24 h (P ＞0.05), but the counts in 48, 96 and 168 h were notably higher in the groups D and C than the group B (P ＜ 0.05), and the differences were more significant over time.Conclusion Our prepared nanoparticles show significant anti-tumor effect for hepatocellular carcinoma bearing nude mice.